Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Bethanechol, a long-acting muscarinic agonist, has been successfully used as a corrective for bowel dysmotility associated with clozapine. Although bethanechol is indicated as a treatment for urinary retention, several reports in the literature have questioned its effectiveness. We report a case in which bethanechol clearly improved urinary retention as an adverse effect of olanzapine.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.